Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program
Go back to Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 236.17 +6.54 (2.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $229.63 | 52 Week High | $160.00 | |||
| Open | $233.25 | 52 Week Low | $95.80 | |||
| Day High | $236.71 | P/E | 43.90 | |||
| Day Low | $231.49 | EPS | $5.38 | |||
| Volume | 954,356 | |||||
